Skip to main content
SpringerLink
Log in

Chemotherapy of malignant gliomas

  • Chemotherapy and immunotherapy of malignant gliomas
  • —A contribution by Japanese Neurosurgery—
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Summary

Chemotherapy of malignant glioma has been discussed in relation to recent advances in experimental and clinical studies. It is now obvious that chemotherapy is of increasing importance in the multidisciplinary treatment of malignant gliomas. Survival time of patients was prolonged by intensive and prolonged chemotherapy and by second treatment upon tumour recurrence. Further progress of chemotherapy will be gained by the progressive accumulation of all experiences, however small, in all the varied routes of approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Blasberg, R. G.: Pharmacodynamics and the bloodbrain barrier. Nat. Cancer Inst. Monogr. 46 (1977) 19–27

    Google Scholar 

  2. Blasberg, R. G.: Pharmacokinetics and metastatic brain tumour chemotherapy. pp 146–164, In: Weiss, L., H. A. Gilbert, J. B. Posner (eds): Brain Metastasis, G. K. Hall and Co., Boston, 1980

    Google Scholar 

  3. Blasberg, R. G., J. Gazendam, C. S. Patlak: Changes in blood-brain transfer parameters induced by hyperosmolar intracarotid infusion and by metastatic tumour growth. pp 307–319, In: Eisenberg, H., R. L. Suddith, (eds): The Cerebral Microvasculature, Plenum Publishing Co., 1980

  4. Brain Tumour Study Group of Japan: Controlled study of the effect of ACNU with radiotherapy for malignant glioma. 41st Congress of the Japan Neurosurgical Society, Tokyo 1982

  5. Chin, H. W., A. B. Young, Y. Maruyama: Survival response of malignant gliomas to radiotherapy with or without BCNU or methyl-CCNU chemotherapy at the University of Kentucky Medical Center. Cancer Treat. Rep. 65, (1981) 41–45

    Google Scholar 

  6. E. O. R. T. C. Brain Tumour Group: Effect of CCNU on survival, rate of objective remission and duration of free interval in patients with malignant brain glioma. Final evaluation. Europ. J. Cancer 14 (1978) 815–856

    Google Scholar 

  7. E. O. R. T. C. Brain Tumour Group. Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. J. Neurosurg. 55 (1981) 27–31

    Google Scholar 

  8. Fewer, D., C. B. Wilson, E. B. Boldrey: The chemotherapy of brain tumours. Clinical experience with carmustine (BCNU) and vincristine. JAMA 222: 549–552, (1972)

    Google Scholar 

  9. Gutin, P. H., C. B. Wilson, A. R. V. Kumar: Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumours. Cancer 35 (1975) 1398–1404

    Google Scholar 

  10. Hasegawa, H., J. C. Allen, B. M. Metha: Enhancement of CNS penetration of methotrexate by hyperosmolar intracarotid mannitol and carcinomatous meningitis. Neurology 29 (1979) 1280–1286

    Google Scholar 

  11. Hasegawa, H., Y. Ushio, T. Hayakawa,: Changes of the blood-brain barrier in experimental metastatic brain tumours. J. Neurosurg. 59 (1983) 304–310

    Google Scholar 

  12. Hildebrand, J., J. Brihaye, L. Wagenknecht,: Combination chemotherapy with 1-(2-chloroethyl-3-cyclohexyl-nitrosourea) (CCNU), vincristine and methotrexate in primary and metastatic brain tumours. A preliminary report. Europ. J. Cancer 9 (1973) 627–634

    Google Scholar 

  13. Hochberg, F. H., L. M. Parker, T. Takvorian,: Highdose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme. J. Neurosurg. 54 (1981) 455–460

    Google Scholar 

  14. Hoshino, T., C. B. Wilson, M. L. Rosenblum: Chemotherapeutic implications of growth fraction and cell cycle time in glioblastomas. J. Neurosurg. 43 (1975) 127–135

    Google Scholar 

  15. Hoshino, T., Chemotherapy of malignant brain tumours: Biology and pharmacokinetics. Noshinkeigeka 8 (1980) 1007–1016 (in Japanese)

    Google Scholar 

  16. Kristiansen, K., S. Hagen, T. Kollevold: Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time. A prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47 (1981) 649–652

    Google Scholar 

  17. Khan, A. B., B. J. D'Souza, M. D. Wharam: Cisplatin therapy in recurrent childhood brain tumours. Cancer Treat. Rep. 66 (1982) 2013–2020

    Google Scholar 

  18. Kumar, A. R. V., J. Renaudin, C. B. Wilson,: Procarbazine hydrochloride in the treatment of brain tumours: Phase 2 study. J. Neurosurg. 40 (1974) 365–371

    Google Scholar 

  19. Lassman, L. P., G. W. Pearce, J. Gang: Sensitivity of intracranial gliomas to vincristine sulphate. Lancet 1 (1965) 296–298

    Google Scholar 

  20. Levin, V. A., P. Kabra: Effectiveness of the nitrosoureas as a function of their lipid solubility in the chemotherapy of experimental rat brain tumours. Cancer Chemother. Rep. 58 (1974) 787–792

    Google Scholar 

  21. Levin, V. A., C. B. Wilson: Chemotherapy: The agents in current use. Sem. Oncology 2 (1975) 63–67

    Google Scholar 

  22. Levin, V. A.., M. Freeman-Dove, H. D. Landahl: Permeability characteristics of brain adjacent of tumours in rats. Arch. Neurol. 32 (1975) 785–791

    Google Scholar 

  23. Levin, V. A., D. C. Crafts, C. B. Wilson: BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumours. Cancer Treat. Rep. 60 (1976) 243–249

    Google Scholar 

  24. Levin, V. A., H. D. Landahl, M. A. Freeman-Dove: The application of brain capillary permeability coefficient measurements to pathological conditions and the selection of agents which cross the blood-brain barrier. J. Pharmacokin. Biopharm. 4 (1976) 499–519

    Google Scholar 

  25. Levin, V. A., W. F. Hoffman, T. L. Pischer: BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumours. Cancer Treat. Re. 62 (1978) 2071–2076

    Google Scholar 

  26. Levin, V. A., C. B. Wilson, R. Davis: A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas. J. Neurosurg. 51 (1979) 526–532

    Google Scholar 

  27. Levin, V. A., M. S. Edwards, D. C. Wright: Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumours. Cancer Treat. Rep. 64 (1980) 237–241

    Google Scholar 

  28. Neuwelt, E. A., J. T. Diehl, L. H. Vu: Monitoring of methotrexate delivery in patients with malignant brain tumours after osmotic blood-brain barrier disruption. Ann. Inter. Med. 94 (1981) 449–454

    Google Scholar 

  29. Pouillart. P., G. Mathe, T. H. Thy: Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26 and CCNU. Results of a phase II trial. Cancer 38 (1976)

  30. Pouillart, T., T. Palangie, M. Poisson: Treatment of adult malignant gliomas. Recent Results Cancer Res 68 (1978) 399–407

    Google Scholar 

  31. Rapoport, S. I., M. Hori, I. Klatzo: Testing of a hypothesis for osmotic opening of the blood-brain barrier. Am. J. Physiol. 223 (1972) 323–331

    Google Scholar 

  32. Reagan, T. J., H. F. Bisel, D. S. Childs: Controlled study of CCNU and radiation therapy in malignant astrocytoma. J. Neurosurg. 44 (1976) 186–190

    Google Scholar 

  33. Rosen, G., F. Ghavimi, A. Nirenberg: High-dose methotrexate with citrovorum factor rescue for the treatment of central nervous system tumours in children. Cancer Treat Rep. 61 (1977) 681–690

    Google Scholar 

  34. Rosenblum, M. L., A. F. Reynolds, K. A. Smith: Chloroethyl-cyclohexyl nitrosourea (CCNU) in the treatment of malignant brain tumours. J. Neurosurg. 39 (1973) 306–314

    Google Scholar 

  35. Rosenblum, M. L., D. V. Dougherty, C. Reese: Agedependent survival of patients with malignant gliomas: Relationship to cell sensitivity. The U. S.-Japanese Conference on Brain Tumour Therapy, Nikko, Japan, 1981

    Google Scholar 

  36. Rosenstock, J. G., A. E. Evans, L. Schut: Response to vincristine of recurrent brain tumours in children. J. Neurosurg. 45 (1976) 135–140

    Google Scholar 

  37. Seiler, R. W., F. Vassella, H. Markwalder: Combination chemotherapy with VM-26 and CCNU in primary malignant brain tumours. Surg. Neurol. 11 (1979) 237–242

    Google Scholar 

  38. Seiler, R. W., A. Zimmermann, H. Markwalder: Adjuvant chemotherapy with VM-26 and CCNU after operation and radiotherapy of high-grade supratentorial astrocytomas. Surg. Neurol. 13 (1980) 65–68

    Google Scholar 

  39. Shapiro, W. R., D. F. Young: CCNU alone and combined with vincristine (VCR) and procarbazine (PCZ) as chemotherapy for malignant glioma. Proc ASCO 17 (1976) 258

    Google Scholar 

  40. Shapiro, W. R., D. F. Young: Treatment of malignant glioma. A controlled study of chemotherapy and irradiation. Arch. Neurol. 33 (1976) 494–500

    Google Scholar 

  41. Shapiro, W. R., J. B. Posner, Y. Ushio: Treatment of meningeal neoplasms. Cancer Treat. Rep. 61 (1977) 733–743

    Google Scholar 

  42. Shimizu, K., Y. Ushio, T. Hayakawa: Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl) -3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats. Cancer Res. 40 (1980) 1341–1343

    Google Scholar 

  43. Sklansky, B. D., R. S. Mann-Kaplan, A. F. Reynolds: 4′-Dimethyl-epipodophyllotosin-β-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasmas. Cancer 33 (1974) 460–467

    Google Scholar 

  44. Takakura, K.: Synchronized chemo-radiotherapy for brain tumours. Shinkei Shinpo 26 (1982) 105–112 (In Japanese with English abstract)

    Google Scholar 

  45. Takeuchi, K.: Effect of bleomycin on brain tumours. Gann 19 (1976) 117–132

    Google Scholar 

  46. Taylor, S. G., L. Nelson, D. Baxter, et al.: Treatment of grade III and IV astrocytoma with dimethyl-triazeno-imidazole carboxamide (DTIC, NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (Me. CCNU, NSC-95441). Cancer 36 (1975) 1269–1276

    Google Scholar 

  47. Tranum, B. L., A. Haut, S. Rivkin: A phase II study of methyl CCNU in the treatment of solid tumours and lymphomas: a Southwest Oncology Group study. Cancer 35 (1975) 1148–1153

    Google Scholar 

  48. Ushio, Y., T. Hayakawa, K. Yamada: Phase III study of methyl-CCNU and bleomycin combination chemotherapy in the treatment of malignant glioma. 7th International Congress of Neurological Surgery, Munich, W. Germany, 1981

  49. Uphouse, W. J., N. Oishi: Case Report: Acute leukemia after semustine (methyl-CCNU) therapy. Cancer Treat. Re. 66 (1982) 1593–1594

    Google Scholar 

  50. Walker, M. D., T. A. Strike: An evaluation of methyl-CCNU, BCNU and radiotherapy in the treatment of malignant glioma. Proc A. Assoc. Cancer Res. 17 (1976) 163

    Google Scholar 

  51. Walker, M. D., S. B. Green, D. P. Byar: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N. Engl. J. Med. 303 (1980) 1323–1329

    Google Scholar 

  52. Wilson, C. B., P. Gutin, E. B. Boldrey: Single-agent chemotherapy of brain tumours. A five-year review. Arch. Neurol. 33 (1976) 739–744

    Google Scholar 

  53. Yamada, K., A. M. Bremer, C. R. West: Intraarterial BCNU therapy in the treatment of metastatic brain tumour from lung carcinoma. A preliminary report. Cancer 44 (1979) 2000–2007

    Google Scholar 

  54. Yamada, K., Y. Ushio, T. Hayakawa: Quantitative autoradiographic measurements of blood-brain barrier permeability in the rat glioma model. J. Neurosurg. 57 (1982) 394–398

    Google Scholar 

  55. Young, R. C., M. D. Walker, G. P. Canellos: Initial clinical trials with methyl-CCNU 1-(2-chloroethyl) -3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU). Cancer 31 (1973) 1164–1169

    Google Scholar 

  56. Young, B., E. H. Oldfield, W. R. Markesbery: Reoperation for glioblastoma. J. Neurosurg. 55 (1981) 917–921

    Google Scholar 

  57. Zander, E., N. de Tribolet, L. Wagenknecht: Combined chemotherapy with VM 26 and BCNU for recurrent malignant gliomas after operation and irradiation. Acta Neurochir. (Wien) 42 (1978) 97–101

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Osaka University Medical School, 1-1-50 Fukushima 553 Fukushima-ku, Osaka, Japan

    Yukitaka Ushio, Toru Hayakawa, Hiroshi Hasegawa, Kazuo Yamada & Norio Arita

Authors
  1. Yukitaka Ushio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toru Hayakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroshi Hasegawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazuo Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Norio Arita
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ushio, Y., Hayakawa, T., Hasegawa, H. et al. Chemotherapy of malignant gliomas. Neurosurg. Rev. 7, 3–12 (1984). https://doi.org/10.1007/BF01743285

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01743285

Keywords

Search

Navigation